Early research indicates significant promise for its dual role in appetite regulation and metabolic enhancement, particularly for patients unresponsive to GLP-1 monotherapy
The steps below are for informational purposes only
These typically improve after reaching stable maintenance doses
Mean IGF-1 rose from 187 ng/mL to 241 ng/mL, well within the physiologic range for young adults
Similarly, immune checkpoint inhibitors may result in a number of adverse side effects including autoimmunity (e.g., bullous pemphigoid, lichen planus pemphigoid, dermatomyositis, etc.)
How to manage: Inject in the evening so you sleep through peak nausea Eat smaller, lighter meals avoid fried, fatty, or spicy food Stay hydrated with at least 2.5 L of water daily Rotate injection sites (abdomen, thigh, upper arm) Week 2 Symptoms Stabilise Dose: still 0.25 mg Most patients report nausea has stabilised or begun to ease